Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Peter McNamaraChief Scientific Officer | Open-market sale10b5-1 plan | 09/30 | 10/02 | 536 sh | $23.04 | $12,349.44 | −1.0% | |
Marcella K. RuddyChief Medical Officer | Open-market sale10b5-1 plan | 05/04 | 05/06 | 1,065 sh | $30.00 | $31,950 | −1.5% | |
Marcella K. RuddyChief Medical Officer | Open-market sale10b5-1 plan | 04/01 | 04/03 | 1,000 sh | $31.05 | $31,050 | −1.4% | |
| Open-market sale10b5-1 plan | 03/06 | 03/09 | 6,262 sh2 trades | $30.17avg. | $188,935 | −10.2% | ||
Marcella K. RuddyChief Medical Officer | Open-market sale10b5-1 plan | 03/06 | 03/09 | 10,000 sh | $30.00 | $300,000 | −12.5% | |
| Open-market sale10b5-1 plan | 03/03–03/04 | 03/05 | 3,299 sh2 trades | $23.53avg. | $77,626.94 | −5.3% | ||
Alise ReicinCEO | Open-market buyAmendment | 02/11 | 03/05 | 2,500 sh | $21.10 | $52,750 | +2.0% | |
Alise ReicinCEO | Open-market buy | 02/11 | 02/12 | 2,500 sh | $21.10 | $52,750 | +1.1% | |
| Open-market buy | 02/10 | 02/11 | 6,000 sh | $21.61 | $129,660 | +23.0% | ||
| Open-market buy | 25/04/09–25/04/11 | 25/04/11 | 141,923 sh8 trades | $16.20avg. | $2,299,014.65 | No record | ||
| Open-market buy | 25/04/07 | 25/04/09 | 500,000 sh2 trades | $17.10avg. | $8,550,000 | No record | ||
Terrance McGuireDirector | Open-market sale | 25/04/07 | 25/04/07 | 500,000 sh | $17.10 | $8,550,000 | −46.6% | |
| Open-market buy | 25/02/05 | 25/02/07 | 789,294 sh2 trades | $50.68avg. | $39,999,977.16 | No record | ||
| Open-market buy | 25/02/05 | 25/02/07 | 4,617 sh | $54.14 | $249,964.38 | No record | ||
Timothy A. SpringerDirector | Open-market buy | 24/10/22 | 24/10/24 | 300,000 sh | $33.59 | $10,077,000 | +7.9% | |
| Open-market buy | 24/09/26 | 24/09/26 | 50,000 sh4 trades | $28.82avg. | $1,440,828.83 | +1.3% |